SCHEMBL18909217

SCHEMBL18909217

CCC(=O)N1CCC(C(=O)N2CCN(C)CC2)CC1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.62
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.49
HSD11B1 P28845 2/20 0.47
ALDH1A1 P00352 3/20 0.46
TSHR P16473 1/20 0.46
HPGD P15428 1/20 0.46
ACACB O00763 1/20 0.45
ACACA Q13085 1/20 0.45
MAPT P10636 1/20 0.44
RIPK1 Q13546 1/20 0.44
EPHX2 P34913 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
KMT2A Q03164 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA4 P43681 1/20 0.43
CHRNB3 Q05901 1/20 0.43
CHRNA6 Q15825 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12296340 0.89 TP53 (0.58) HTTLMNATP53HSD11B1ALDH1A1
SCHEMBL13779924 0.87 HTT (0.54) HTTLMNATP53HSD11B1ALDH1A1
SCHEMBL2075903 0.85 HTT (0.81) HTTLMNAHSD11B1ALDH1A1TSHR
SCHEMBL21280863 0.85 HTT (0.56) HTTLMNATP53HSD11B1ALDH1A1
SCHEMBL22672849 0.84 ALDH1A1 (0.67) HTTLMNATP53HSD11B1ALDH1A1
SCHEMBL8194135 0.83 HTT (0.71) HTTLMNAHSD11B1ALDH1A1TSHR
SCHEMBL802314 0.83 CYP1A2 (0.54) HTTLMNAALDH1A1MAPTKMT2A
SCHEMBL12518918 0.82 ALDH1A1 (0.70) HTTLMNATP53HSD11B1ALDH1A1
SCHEMBL22030326 0.82 HTT (0.53) HTTLMNATP53HSD11B1ALDH1A1
SCHEMBL18909225 0.81 CHRNB2 (0.70) TP53HSD11B1ALDH1A1HPGDACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596072-B1 PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-06-22 EP disclosed
EP-3380474-B1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF HOFFMANN LA ROCHE (CH) 2019-08-21 EP disclosed
WO-2017140825-A1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-08-24 WO disclosed
WO-2017089390-A1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-06-01 WO disclosed